Citi Call 215 PGR 20.06.2024/ DE000KJ4DD45 /
2024-04-09 8:17:13 AM | Chg.- | Bid10:00:17 PM | Ask10:00:17 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.02EUR | - | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 215.00 - | 2024-06-20 | Call |
GlobeNewswire
04-25
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-22
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-22
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire
04-19
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire
04-18
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire
04-18
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
04-18
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
GlobeNewswire
04-18
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...
GlobeNewswire
04-17
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American ...
GlobeNewswire
04-16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-15
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatm...
GlobeNewswire
04-15
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-15
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...
GlobeNewswire
04-11
PyroGenesis Announces That Lab Strength Tests Achieve 45% Above Target for Green Cement Additive Pro...